Global Implanted Central Venous Access Devices Market Growth 2025-2031

The global Implanted Central Venous Access Devices market size is predicted to grow from US$ 567 million in 2025 to US$ 681 million in 2031; it is expected to grow at a CAGR of 3.1% from 2025 to 2031.

Implanted Central Venous Access Devices (CVADs) are medical devices surgically placed under the skin to provide long-term venous access for patients requiring frequent or continuous intravenous therapy. These devices consist of a catheter inserted into a large central vein and a small port or reservoir placed under the skin, typically in the chest or upper arm. CVADs are commonly used for chemotherapy, long-term antibiotic therapy, parenteral nutrition, and other medical treatments. Their fully implanted design minimizes infection risks and enhances patient comfort compared to external catheters.

United States market for Implanted Central Venous Access Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Implanted Central Venous Access Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Implanted Central Venous Access Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Implanted Central Venous Access Devices players cover BD, AngioDynamics, ICU Medical, B. Braun, PFM Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Implanted Central Venous Access Devices Industry Forecast” looks at past sales and reviews total world Implanted Central Venous Access Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Implanted Central Venous Access Devices sales for 2025 through 2031. With Implanted Central Venous Access Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implanted Central Venous Access Devices industry.

This Insight Report provides a comprehensive analysis of the global Implanted Central Venous Access Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implanted Central Venous Access Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implanted Central Venous Access Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implanted Central Venous Access Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implanted Central Venous Access Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Implanted Central Venous Access Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Titanium Implantable Port
Plastic Implantable Port

Segmentation by Application:
Intravenous Chemotherapy
Nutritional Support Therapy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
AngioDynamics
ICU Medical
B. Braun
PFM Medical
Vygon
Districlass
PakuMed
Linhua Medical
Fresenius
Sophysa
Baxter

Key Questions Addressed in this Report

What is the 10-year outlook for the global Implanted Central Venous Access Devices market?

What factors are driving Implanted Central Venous Access Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Implanted Central Venous Access Devices market opportunities vary by end market size?

How does Implanted Central Venous Access Devices break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.